Technical Manual

Industry Program Onboarding and Information

Please liaise directly with your nominated speakers and chairs to confirm their availability and requirements.

All speakers and chairs must be registered to be able to attend and present at the session. You can use one of your complimentary registrations to register your speaker for free or you can purchase additional registrations. 

If you are not sure what registration type is more suitable for your speakers, please contact us at

Onboarding Form

Please complete industry program onboarding form as required by the deadline indicated in the checklist and deadlines. Failure to do so may result in our inability to provide the appropriate service/s and may result in additional fees.

You will be required to provide:

  • Session title
  • Synopsis
  • Format of presentation e.g.
    • 10:20 – Introduction (5 mins)
    • 10:25 – Speaker 1 (15 mins)
    • 10:40 – Speaker 2 (15 mins)
    • 11:55 – Speaker 3 (15 mins)
    • 11:10 – Q&A (25 mins)
  • Location of presentation (live or virtually)
  • Chair name and contact details (including bio and photo)
  • Presenter name and contact details (including bio and photo)

If you require any assistance with this, please contact us.

Jennifa Vo
Project Manager

Speaker Preparation

ALL presentations, regardless of virtual or in-person, need to be pre-recorded and submitted to the congress organisers by the specified date. If you have in-person presenters they can still present live however the pre-recorded content will be used as a back up for virtual attendees in the case of technical faults on the day of presentation.

In-person speakers
  • In-person speakers will submit their pre-recorded presentation by the due date listed on this document. This pre-recording will only be used if the facilities fail on the day and the virtual attendees cannot access the in-room stream link.
  • On the day of presentation, speakers will need to submit their presentation slides onsite to our speaker preparation room where you will be able to go through the slides and rehearse with your speakers.
  • Room setup (TBC)
  • All times listed include set-up, presentation and pack up time. Pre-presentation room access may be available for some timeslots and subject to agreement with the APGC 2022 Organisers.
Virtual speakers
Pre-record + live Q&A
  • If you wish for the session to be delivered by pre-recorded presentation, please ensure the pre-recorded presentation/session is uploaded by 4 July 2022.
  • This presentation will be played to the virtual attendees. Virtual speakers will then join the zoom link for the live Q&A that will be streamed to the Kuala Lumpur Convention Centre and the virtual platform.
  • The zoom links will be shared with industry partners 7 days prior to the congress commencement. It is the responsibility of the industry partner to share this information with the speaker.
Virtual speakers
Live stream + live Q&A
  • If you wish to deliver a live session and not pre-record, please notify us in writing.  We strongly encourage pre-recording the presentations to avoid technical faults on the day.
  • This presentation will be played to the virtual attendees. Virtual speakers will then join the zoom link for the live Q&A that will be streamed to the Kuala Lumpur Convention Centre and the virtual platform.
  • The zoom links will be shared with industry partners 7 days prior to the congress commencement. It is the responsibility of the industry partner to share this information with the speaker.
Greenroom/Zoom room
  • The green room (zoom link) is open just (approximately 10- minutes) prior to the session commencement. The speakers/moderators will have their audio and visual tested by the technician located in the zoom room. The technician will provide instruction to the speakers prior to going live to Kuala Lumpur and virtual attendees.
  • Questions will be submitted through the virtual platform. These will then be read out by the chairperson.

Live Polling

Polling questions must be submitted by Monday 4 July 2022 to the congress organisers to enable pre-setting in the system.

Polling responses can feature:

  • yes / no;
  • multiple choice;
  • single choice; and
  • can be controlled by moderator

Industry Program Rehearsal Schedule

All industry partners hosting an industry program session with a virtual component are offered a rehearsal with your symposium coordinator.. We recommend that you invite your speakers and chairs for the symposium to join the rehearsals.

Maximum rehearsal time is limited to 30 minutes per individual symposium.

Pre-booking of rehearsal time is mandatory and industry symposium rehearsals are only available to industry between the following dates and times:

  • Monday 4 July 2022 – Friday 8 July 2022
    • 07:00 – 10:00 GMT+8
    • 12:00 – 15:00 GMT+8

On the day delivery

In-person presentations from KLCC

Speaker setup: Your speaker/s and chair/s will be presenting in your session room at the Kuala Lumpur Convention Centre. They will have a lectern, stage, microphone and slide advancer for presentation. The presentation will be pre-loaded to the screen via the speaker’s preparation room.

Moderator/Q&A format: Questions will be submitted via the platform. It is recommended the chairperson/moderator is engaging, interactive with delegates, and who is comfortable with technology. They will be required to monitor questions that are being sent through the platform via a tablet and/or foldback monitor which will be provided.

Delegate view: We will stream the video and audio of the session via the virtual platform for virtual delegates. The session room will be setup to allow seating and interactivity for in-person delegates.

Virtual presentation via Zoom

Speaker setup: Your presenter/s and chair/s will deliver the session online via Zoom links (similar to APGC 2022). They can present live or we strongly recommend pre-recording their presentations which will be played on the day of session.

Moderator/Q&A format: Questions will be submitted via the platform. It is recommended the virtual option includes a virtual chairperson AND an in-person chairperson. The virtual chairperson will be able to moderate the questions being submitted through the platform. The purpose of the in-person moderator is to ensure the delegates in Kuala Lumpur feel engaged with, and to encourage participation from the Kuala Lumpur delegates. 

Delegate view: The virtual stream will be pushed via the virtual platform for virtual attendees, and on screen in the session room at the Kuala Lumpur Convention Centre for in-person delegates. 



At Iridex, we are redefining the glaucoma treatment paradigm with a versatile range of non-incisional, laser-based therapies: MicroPulse Laser Trabeculoplasty, MicroPulse Transscleral Laser Therapy, and Continuous-Wave Transscleral Cyclophotocoagulation. These therapies
provide physicians safe, effective, and versatile treatment options for a wide variety of glaucoma types and severities, to significantly reduce intraocular pressure and slow the progression of vision loss. More than 200,000 patients have been treated since 2015 with MicroPulse® TLT using the MicroPulse P3® Delivery Device. Visit to learn how ophthalmologists and patients benefit from our non-incisional glaucoma procedures.


Kalson Surgical


Bayer Co. (Malaysia) Sdn Bhd

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. For more information, go to



DKSH is the leading growth partner for pharmaceutical companies in Asia. Our experts provide a range of integrated Market Expansion Services across the entire value chain, ranging from registration through to marketing, promotion and distribution.
Our capillary network reaches more than 130,000 hospitals, clinics, pharmacies, doctors and drugstores in Asia. Products are transported, stored and distributed efficiently thanks to our unmatched capacities and expertise in the region. Our solid infrastructure and dedication to compliance and quality reduce business risks for our partners.
We are committed to delivering the results you need to be successful. That’s why we continuously invest in our sales and marketing organization, which is fully embedded in our operations. Our teams work with clear measurements, activity-driven KPIs and standardized brand planning processes across the region. They are supported by regional Sales and Marketing Excellence and Business Development teams, allowing us to duplicate success across markets.
Headquartered and publicly listed in Switzerland, our local experts provide services to pharmaceutical companies in 13 Asian markets.

Glaukos Aventisin 500x500

Glaukos Corporation / Aventisin

Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.

We were the first company to bring to market Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure that revolutionized the treatment and management of glaucoma. In 2012, we launched our first MIGS device—the iStent®—in the United States, followed by our next-generation iStent inject® device in September 2018 and iStent inject® W in September 2020.

In November 2019, Glaukos acquired Avedro, maker of the first and only FDA-approved cross-linking technology for progressive keratoconus. And we continue to seek to leverage our platform technologies to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies for
glaucoma, corneal health, and retinal diseases.

Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol “GKOS”. Our global headquarters is located in Aliso Viejo, California, and we have additional locations in 9 regions around the world.


TRB Chemedica Malaysia

A subsidiary company of TRB CHEMEDICA INTERNATIONAL SA (Switzerland) established for almost 34 years in Malaysia, specialising in the use of hyaluronic acid in ophthalmology, rheumatology and orthopaedic for the management of ocular dryness, osteoarthritis and tendinopathy.

Nova Eye

Nova Eye Medical

With a legacy that spans more than 30 years in ophthalmology, Nova Eye Medical designs, develops, manufactures and markets a portfolio of proprietary glaucoma treatment technologies. Underpinning each of these technologies is our commitment to advance clinical outcomes and improve patient quality of life.



iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD).
Our devices cover automated fundus imaging systems, perimeters, and handheld rebound tonometers. iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.
We believe that ophthalmic care must be accessible, effortless, and reliable, and our aim is to establish the next level of eye care.



Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. Learn more at



As a specialized company dedicated to ophthalmology, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and devices. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan and its products now reach patients in over 60 countries. With scientific knowledge and organizational capabilities nurtured over a 130-year history, Santen provides products and services to contribute to the well-being of patients, their loved ones and consequently to society. For more information, please visit